Tests thymosin β4 (T4) in a combined chronic ethanol feeding plus LPS (binge-on-chronic) mouse model of alcoholic liver disease—more clinically representative than either model alone. T4 prevented ethanol/LPS-mediated increases in liver injury enzymes, oxidative stress markers, pro-inflammatory cytokines, and fibrosis-related proteins. Demonstrates TB4's hepatoprotective efficacy specifically in alcohol-related liver disease—extending TB4's anti-fibrotic liver evidence beyond non-alcoholic fatty liver and chemical injury models to the most prevalent cause of cirrhosis worldwide.
Shah, Ruchi; Reyes-Gordillo, Karina; Cheng, Ying; Varatharajalu, Ravi; Ibrahim, Joseph; Lakshman, M Raj